Does the media refer more to EW or HSIC?

In the previous week, Edwards Lifesciences had 16 more articles in the media than Henry Schein. MarketBeat recorded 25 mentions for Edwards Lifesciences and 9 mentions for Henry Schein. Edwards Lifesciences' average media sentiment score of 1.62 beat Henry Schein's score of 0.93 indicating that Edwards Lifesciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Edwards Lifesciences 25 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Henry Schein 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor AMN or EW?

In the previous week, Edwards Lifesciences had 17 more articles in the media than AMN Healthcare Services. MarketBeat recorded 25 mentions for Edwards Lifesciences and 8 mentions for AMN Healthcare Services. Edwards Lifesciences' average media sentiment score of 1.62 beat AMN Healthcare Services' score of 0.82 indicating that Edwards Lifesciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AMN Healthcare Services 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Edwards Lifesciences 25 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media refer more to EW or ABT?

In the previous week, Abbott Laboratories had 32 more articles in the media than Edwards Lifesciences. MarketBeat recorded 57 mentions for Abbott Laboratories and 25 mentions for Edwards Lifesciences. Edwards Lifesciences' average media sentiment score of 1.62 beat Abbott Laboratories' score of 1.34 indicating that Edwards Lifesciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Edwards Lifesciences 25 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Abbott Laboratories 46 Very Positive mention(s) 5 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to EW or ISRG?

In the previous week, Intuitive Surgical had 2 more articles in the media than Edwards Lifesciences. MarketBeat recorded 27 mentions for Intuitive Surgical and 25 mentions for Edwards Lifesciences. Edwards Lifesciences' average media sentiment score of 1.62 beat Intuitive Surgical's score of 0.81 indicating that Edwards Lifesciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Edwards Lifesciences 25 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Intuitive Surgical 20 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor SYK or EW?

In the previous week, Stryker had 48 more articles in the media than Edwards Lifesciences. MarketBeat recorded 73 mentions for Stryker and 25 mentions for Edwards Lifesciences. Edwards Lifesciences' average media sentiment score of 1.62 beat Stryker's score of 1.44 indicating that Edwards Lifesciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Stryker 64 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Edwards Lifesciences 25 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Edwards Lifesciences (EW) Competitors

$89.89 +0.06 (+0.07%)

As of 08/21/2026 03:58 PM Eastern

Compare

EW vs. HSIC, AMN, ABT, ISRG, and SYK

Should you buy Edwards Lifesciences stock or one of its competitors? Edwards Lifesciences's main competitors and comparable companies include Henry Schein (HSIC), AMN Healthcare Services (AMN), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), and Stryker (SYK). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does Edwards Lifesciences compare to Henry Schein?

Edwards Lifesciences (NYSE:EW) and Henry Schein (NASDAQ:HSIC) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and media sentiment.

Edwards Lifesciences has higher earnings, but lower revenue than Henry Schein. Henry Schein is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Edwards Lifesciences	$6.07B	8.53	$1.07B	$1.74	51.66
Henry Schein	$13.18B	0.75	$398M	$3.43	25.80

79.5% of Edwards Lifesciences shares are held by institutional investors. Comparatively, 96.6% of Henry Schein shares are held by institutional investors. 0.3% of Edwards Lifesciences shares are held by insiders. Comparatively, 0.9% of Henry Schein shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Edwards Lifesciences has a net margin of 15.43% compared to Henry Schein's net margin of 2.96%. Henry Schein's return on equity of 15.97% beat Edwards Lifesciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Edwards Lifesciences	15.43%	15.68%	12.05%
Henry Schein	2.96%	15.97%	5.56%

Edwards Lifesciences has a beta of 0.85, suggesting that its stock price is 15% less volatile than the broader market. Comparatively, Henry Schein has a beta of 0.8, suggesting that its stock price is 20% less volatile than the broader market.

In the previous week, Edwards Lifesciences had 16 more articles in the media than Henry Schein. MarketBeat recorded 25 mentions for Edwards Lifesciences and 9 mentions for Henry Schein. Edwards Lifesciences' average media sentiment score of 1.62 beat Henry Schein's score of 0.93 indicating that Edwards Lifesciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Edwards Lifesciences	25 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Henry Schein	6 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Edwards Lifesciences currently has a consensus target price of $100.27, suggesting a potential upside of 11.55%. Henry Schein has a consensus target price of $92.93, suggesting a potential upside of 5.01%. Given Edwards Lifesciences' stronger consensus rating and higher possible upside, equities analysts plainly believe Edwards Lifesciences is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Edwards Lifesciences	0 Sell rating(s)	6 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.74
Henry Schein	1 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.47

Summary

Edwards Lifesciences beats Henry Schein on 11 of the 16 factors compared between the two stocks.

How does Edwards Lifesciences compare to AMN Healthcare Services?

AMN Healthcare Services (NYSE:AMN) and Edwards Lifesciences (NYSE:EW) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, media sentiment, analyst recommendations, dividends and profitability.

99.2% of AMN Healthcare Services shares are held by institutional investors. Comparatively, 79.5% of Edwards Lifesciences shares are held by institutional investors. 1.1% of AMN Healthcare Services shares are held by company insiders. Comparatively, 0.3% of Edwards Lifesciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

AMN Healthcare Services has a beta of 0.4, meaning that its stock price is 60% less volatile than the broader market. Comparatively, Edwards Lifesciences has a beta of 0.85, meaning that its stock price is 15% less volatile than the broader market.

In the previous week, Edwards Lifesciences had 17 more articles in the media than AMN Healthcare Services. MarketBeat recorded 25 mentions for Edwards Lifesciences and 8 mentions for AMN Healthcare Services. Edwards Lifesciences' average media sentiment score of 1.62 beat AMN Healthcare Services' score of 0.82 indicating that Edwards Lifesciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AMN Healthcare Services	4 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Edwards Lifesciences	25 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Edwards Lifesciences has a net margin of 15.43% compared to AMN Healthcare Services' net margin of 3.06%. AMN Healthcare Services' return on equity of 19.92% beat Edwards Lifesciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AMN Healthcare Services	3.06%	19.92%	5.93%
Edwards Lifesciences	15.43%	15.68%	12.05%

Edwards Lifesciences has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AMN Healthcare Services	$3.43B	0.39	-$95.70M	$2.68	12.87
Edwards Lifesciences	$6.07B	8.53	$1.07B	$1.74	51.66

AMN Healthcare Services presently has a consensus target price of $31.43, suggesting a potential downside of 8.85%. Edwards Lifesciences has a consensus target price of $100.27, suggesting a potential upside of 11.55%. Given Edwards Lifesciences' stronger consensus rating and higher possible upside, analysts clearly believe Edwards Lifesciences is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AMN Healthcare Services	2 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.22
Edwards Lifesciences	0 Sell rating(s)	6 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.74

Summary

Edwards Lifesciences beats AMN Healthcare Services on 12 of the 16 factors compared between the two stocks.

How does Edwards Lifesciences compare to Abbott Laboratories?

Edwards Lifesciences (NYSE:EW) and Abbott Laboratories (NYSE:ABT) are both large-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership, earnings and profitability.

Edwards Lifesciences has a beta of 0.85, meaning that its stock price is 15% less volatile than the broader market. Comparatively, Abbott Laboratories has a beta of 0.59, meaning that its stock price is 41% less volatile than the broader market.

79.5% of Edwards Lifesciences shares are held by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are held by institutional investors. 0.3% of Edwards Lifesciences shares are held by company insiders. Comparatively, 0.5% of Abbott Laboratories shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Abbott Laboratories has higher revenue and earnings than Edwards Lifesciences. Abbott Laboratories is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Edwards Lifesciences	$6.07B	8.53	$1.07B	$1.74	51.66
Abbott Laboratories	$44.33B	4.55	$6.52B	$3.09	37.74

In the previous week, Abbott Laboratories had 32 more articles in the media than Edwards Lifesciences. MarketBeat recorded 57 mentions for Abbott Laboratories and 25 mentions for Edwards Lifesciences. Edwards Lifesciences' average media sentiment score of 1.62 beat Abbott Laboratories' score of 1.34 indicating that Edwards Lifesciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Edwards Lifesciences	25 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Abbott Laboratories	46 Very Positive mention(s)	5 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Edwards Lifesciences currently has a consensus price target of $100.27, suggesting a potential upside of 11.55%. Abbott Laboratories has a consensus price target of $118.67, suggesting a potential upside of 1.75%. Given Edwards Lifesciences' higher possible upside, equities research analysts plainly believe Edwards Lifesciences is more favorable than Abbott Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Edwards Lifesciences	0 Sell rating(s)	6 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.74
Abbott Laboratories	0 Sell rating(s)	4 Hold rating(s)	20 Buy rating(s)	3 Strong Buy rating(s)	2.96

Edwards Lifesciences has a net margin of 15.43% compared to Abbott Laboratories' net margin of 11.65%. Abbott Laboratories' return on equity of 17.69% beat Edwards Lifesciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Edwards Lifesciences	15.43%	15.68%	12.05%
Abbott Laboratories	11.65%	17.69%	9.44%

Summary

Abbott Laboratories beats Edwards Lifesciences on 9 of the 17 factors compared between the two stocks.

How does Edwards Lifesciences compare to Intuitive Surgical?

Edwards Lifesciences (NYSE:EW) and Intuitive Surgical (NASDAQ:ISRG) are both large-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, earnings, valuation, institutional ownership, media sentiment and risk.

Edwards Lifesciences currently has a consensus price target of $100.27, indicating a potential upside of 11.55%. Intuitive Surgical has a consensus price target of $508.68, indicating a potential upside of 34.28%. Given Intuitive Surgical's higher probable upside, analysts clearly believe Intuitive Surgical is more favorable than Edwards Lifesciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Edwards Lifesciences	0 Sell rating(s)	6 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.74
Intuitive Surgical	1 Sell rating(s)	8 Hold rating(s)	22 Buy rating(s)	0 Strong Buy rating(s)	2.68

Edwards Lifesciences has a beta of 0.85, indicating that its stock price is 15% less volatile than the broader market. Comparatively, Intuitive Surgical has a beta of 1.46, indicating that its stock price is 46% more volatile than the broader market.

In the previous week, Intuitive Surgical had 2 more articles in the media than Edwards Lifesciences. MarketBeat recorded 27 mentions for Intuitive Surgical and 25 mentions for Edwards Lifesciences. Edwards Lifesciences' average media sentiment score of 1.62 beat Intuitive Surgical's score of 0.81 indicating that Edwards Lifesciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Edwards Lifesciences	25 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Intuitive Surgical	20 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Intuitive Surgical has higher revenue and earnings than Edwards Lifesciences. Intuitive Surgical is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Edwards Lifesciences	$6.07B	8.53	$1.07B	$1.74	51.66
Intuitive Surgical	$10.06B	13.30	$2.86B	$8.73	43.39

Intuitive Surgical has a net margin of 28.45% compared to Edwards Lifesciences' net margin of 15.43%. Intuitive Surgical's return on equity of 16.91% beat Edwards Lifesciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Edwards Lifesciences	15.43%	15.68%	12.05%
Intuitive Surgical	28.45%	16.91%	14.83%

79.5% of Edwards Lifesciences shares are owned by institutional investors. Comparatively, 83.6% of Intuitive Surgical shares are owned by institutional investors. 0.3% of Edwards Lifesciences shares are owned by company insiders. Comparatively, 0.6% of Intuitive Surgical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Intuitive Surgical beats Edwards Lifesciences on 13 of the 16 factors compared between the two stocks.

How does Edwards Lifesciences compare to Stryker?

Stryker (NYSE:SYK) and Edwards Lifesciences (NYSE:EW) are both large-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, profitability, earnings, analyst recommendations, media sentiment, institutional ownership and dividends.

Stryker has a beta of 0.76, meaning that its stock price is 24% less volatile than the broader market. Comparatively, Edwards Lifesciences has a beta of 0.85, meaning that its stock price is 15% less volatile than the broader market.

Edwards Lifesciences has a net margin of 15.43% compared to Stryker's net margin of 14.43%. Stryker's return on equity of 23.63% beat Edwards Lifesciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stryker	14.43%	23.63%	11.39%
Edwards Lifesciences	15.43%	15.68%	12.05%

Stryker presently has a consensus price target of $386.28, suggesting a potential upside of 17.10%. Edwards Lifesciences has a consensus price target of $100.27, suggesting a potential upside of 11.55%. Given Stryker's stronger consensus rating and higher probable upside, equities research analysts plainly believe Stryker is more favorable than Edwards Lifesciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stryker	0 Sell rating(s)	6 Hold rating(s)	17 Buy rating(s)	1 Strong Buy rating(s)	2.79
Edwards Lifesciences	0 Sell rating(s)	6 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.74

Stryker has higher revenue and earnings than Edwards Lifesciences. Stryker is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stryker	$25.12B	5.04	$3.25B	$9.65	34.18
Edwards Lifesciences	$6.07B	8.53	$1.07B	$1.74	51.66

77.1% of Stryker shares are owned by institutional investors. Comparatively, 79.5% of Edwards Lifesciences shares are owned by institutional investors. 4.6% of Stryker shares are owned by company insiders. Comparatively, 0.3% of Edwards Lifesciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Stryker had 48 more articles in the media than Edwards Lifesciences. MarketBeat recorded 73 mentions for Stryker and 25 mentions for Edwards Lifesciences. Edwards Lifesciences' average media sentiment score of 1.62 beat Stryker's score of 1.44 indicating that Edwards Lifesciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Stryker	64 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Edwards Lifesciences	25 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

Stryker beats Edwards Lifesciences on 9 of the 16 factors compared between the two stocks.

Get Edwards Lifesciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

EW vs. The Competition

Export

Metric	Edwards Lifesciences	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$51.72B	$5.89B	$7.27B	$24.12B
Dividend Yield	N/A	1.75%	2.54%	3.71%
P/E Ratio	51.66	26.30	270.69	30.15
Price / Sales	8.53	80.51	689.03	17.54
Price / Cash	31.50	33.20	76.89	32.42
Price / Book	4.83	6.20	13.43	6.77
Net Income	$1.07B	$149.51M	$3.46B	$1.07B
7 Day Performance	-1.77%	0.85%	2.15%	-0.66%
1 Month Performance	6.53%	8.27%	6.17%	2.44%
1 Year Performance	9.95%	7.68%	24.96%	14.85%

Edwards Lifesciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
EW Edwards Lifesciences	4.3435 of 5 stars	$89.89 +0.1%	$100.27 +11.6%	+10.8%	$51.72B	$6.07B	51.66	16,000	Positive News
HSIC Henry Schein	3.1861 of 5 stars	$89.52 -0.3%	$92.27 +3.1%	+29.7%	$10.00B	$13.18B	26.10	25,000	Analyst Forecast
AMN AMN Healthcare Services	2.1251 of 5 stars	$34.46 -0.1%	$31.43 -8.8%	+75.3%	$1.34B	$2.73B	12.86	2,664
ABT Abbott Laboratories	4.5084 of 5 stars	$110.68 -0.5%	$118.67 +7.2%	-11.6%	$192.51B	$44.33B	35.82	115,000	Trending News
ISRG Intuitive Surgical	4.4966 of 5 stars	$390.33 -1.1%	$508.68 +30.3%	-19.4%	$139.37B	$10.06B	44.71	17,021	Trending News Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:EW) was last updated on 8/22/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Edwards Lifesciences (EW) Competitors

EW vs. HSIC, AMN, ABT, ISRG, and SYK

How does Edwards Lifesciences compare to Henry Schein?

Summary

How does Edwards Lifesciences compare to AMN Healthcare Services?

Summary

How does Edwards Lifesciences compare to Abbott Laboratories?

Summary

How does Edwards Lifesciences compare to Intuitive Surgical?

Summary

How does Edwards Lifesciences compare to Stryker?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EW vs. The Competition

Edwards Lifesciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Edwards Lifesciences (EW) Competitors

EW vs. HSIC, AMN, ABT, ISRG, and SYK

How does Edwards Lifesciences compare to Henry Schein?

Which has better earnings and valuation, EW or HSIC?

Do institutionals and insiders hold more shares of EW or HSIC?

Is EW or HSIC more profitable?

Which has more volatility & risk, EW or HSIC?

Does the media refer more to EW or HSIC?

Do analysts prefer EW or HSIC?

Summary

How does Edwards Lifesciences compare to AMN Healthcare Services?

Do institutionals & insiders believe in AMN or EW?

Which has more volatility and risk, AMN or EW?

Does the media favor AMN or EW?

Is AMN or EW more profitable?

Which has better valuation & earnings, AMN or EW?

Do analysts rate AMN or EW?

Summary

How does Edwards Lifesciences compare to Abbott Laboratories?

Which has more volatility and risk, EW or ABT?

Do institutionals and insiders hold more shares of EW or ABT?

Which has stronger valuation and earnings, EW or ABT?

Does the media refer more to EW or ABT?

Do analysts recommend EW or ABT?

Is EW or ABT more profitable?

Summary

How does Edwards Lifesciences compare to Intuitive Surgical?

Do analysts rate EW or ISRG?

Which has more risk & volatility, EW or ISRG?

Does the media refer more to EW or ISRG?

Which has better valuation and earnings, EW or ISRG?

Is EW or ISRG more profitable?

Do institutionals and insiders have more ownership in EW or ISRG?

Summary

How does Edwards Lifesciences compare to Stryker?

Which has more risk and volatility, SYK or EW?

Is SYK or EW more profitable?

Do analysts rate SYK or EW?

Which has better earnings and valuation, SYK or EW?

Do institutionals & insiders hold more shares of SYK or EW?

Does the media favor SYK or EW?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EW vs. The Competition

Edwards Lifesciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools